title: Crystal structure of an archaeal pentameric riboflavin synthase in complex with a substrate analog inhibitor: stereochemical implications.
abstract: Whereas eubacterial and eukaryotic riboflavin synthases form homotrimers, archaeal riboflavin synthases from Methanocaldococcus jannaschii and Methanothermobacter thermoautrophicus are homopentamers with sequence similarity to the 6,7-dimethyl-8-ribityllumazine synthase catalyzing the penultimate step in riboflavin biosynthesis. Recently it could be shown that the complex dismutation reaction catalyzed by the pentameric M. jannaschii riboflavin synthase generates riboflavin with the same regiochemistry as observed for trimeric riboflavin synthases. Here we present crystal structures of the pentameric riboflavin synthase from M. jannaschii and its complex with the substrate analog inhibitor, 6,7-dioxo-8-ribityllumazine. The complex structure shows five active sites located between adjacent monomers of the pentamer. Each active site can accommodate two substrate analog molecules in anti-parallel orientation. The topology of the two bound ligands at the active site is well in line with the known stereochemistry of a pentacyclic adduct of 6,7-dimethyl-8-ribityllumazine that has been shown to serve as a kinetically competent intermediate. The pentacyclic intermediates of trimeric and pentameric riboflavin synthases are diastereomers.
authors.affiliation: Max-Planck-Institut für Biochemie, Abteilung für Strukturforschung, Martinsried, Germany. ramsperg@biochem.mpg.de
authors.forename: Arne
authors.initials: A
authors.lastname: Ramsperger
authors.forename: Martin
authors.initials: M
authors.lastname: Augustin
authors.forename: Ann-Kathrin
authors.initials: AK
authors.lastname: Schott
authors.forename: Stefan
authors.initials: S
authors.lastname: Gerhardt
authors.forename: Tobias
authors.initials: T
authors.lastname: Krojer
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Eisenreich
authors.forename: Boris
authors.initials: B
authors.lastname: Illarionov
authors.forename: Mark
authors.initials: M
authors.lastname: Cushman
authors.forename: Adelbert
authors.initials: A
authors.lastname: Bacher
authors.forename: Robert
authors.initials: R
authors.lastname: Huber
authors.forename: Markus
authors.initials: M
authors.lastname: Fischer
mesh_terms: D000595:Amino Acid Sequence; D001105:Archaea / Q000201:enzymology* / Q000378:metabolism; D001665:Binding Sites; D003001:Cloning, Molecular; D018360:Crystallography, X-Ray; D007700:Kinetics; D017013:Methanobacteriaceae / Q000378:metabolism; D008956:Models, Chemical; D008958:Models, Molecular; D008968:Molecular Conformation; D008969:Molecular Sequence Data; D009097:Multienzyme Complexes / Q000737:chemistry; D011487:Protein Conformation; D017433:Protein Structure, Secondary; D011621:Pteridines / Q000737:chemistry* / Q000378:metabolism; D012255:Ribitol / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D012256:Riboflavin / Q000737:chemistry; D012258:Riboflavin Synthase / Q000737:chemistry*; D012266:Ribose / Q000737:chemistry; D017386:Sequence Homology, Amino Acid; D013237:Stereoisomerism
chemical_list: C508152:6,7-dioxo-8-ribityllumazine; D009097:Multienzyme Complexes; D011621:Pteridines; D012255:Ribitol; D012266:Ribose; C044822:6,7-dimethyl-8-ribityllumazine synthase; D012258:Riboflavin Synthase; D012256:Riboflavin